Element Biosciences unveiled Vitari, a high‑throughput sequencer that promises $100 30× genomes by delivering 3 Tb per run; at the same time vendors are launching spatial and single‑cell platforms to push down per‑sample costs. Product briefs highlight Singular Genomics’ G4X platform for high‑plex spatial analysis and Parse Biosciences’ Evercode v4 for large‑scale single‑cell studies. The technology push is poised to compress sequencing cost and turnaround, change experimental design for large cohorts, and shift economics of clinical genomics. Labs and service providers face decisions on instrument mix, throughput planning, and computational infrastructure to absorb higher data volumes and new assay modalities.